Frontiers in Cardiovascular Medicine (Jun 2022)

Machine Learning Patient-Specific Prediction of Heart Failure Hospitalization Using Cardiac MRI-Based Phenotype and Electronic Health Information

  • Aidan K. Cornhill,
  • Steven Dykstra,
  • Alessandro Satriano,
  • Alessandro Satriano,
  • Alessandro Satriano,
  • Dina Labib,
  • Dina Labib,
  • Dina Labib,
  • Yoko Mikami,
  • Yoko Mikami,
  • Yoko Mikami,
  • Jacqueline Flewitt,
  • Easter Prosio,
  • Sandra Rivest,
  • Rosa Sandonato,
  • Andrew G. Howarth,
  • Andrew G. Howarth,
  • Andrew G. Howarth,
  • Carmen Lydell,
  • Carmen Lydell,
  • Carmen Lydell,
  • Carmen Lydell,
  • Cathy A. Eastwood,
  • Cathy A. Eastwood,
  • Hude Quan,
  • Hude Quan,
  • Nowell Fine,
  • Nowell Fine,
  • Joon Lee,
  • Joon Lee,
  • Joon Lee,
  • James A. White,
  • James A. White,
  • James A. White

DOI
https://doi.org/10.3389/fcvm.2022.890904
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundHeart failure (HF) hospitalization is a dominant contributor of morbidity and healthcare expenditures in patients with systolic HF. Cardiovascular magnetic resonance (CMR) imaging is increasingly employed for the evaluation of HF given capacity to provide highly reproducible phenotypic markers of disease. The combined value of CMR phenotypic markers and patient health information to deliver predictions of future HF events has not been explored. We sought to develop and validate a novel risk model for the patient-specific prediction of time to HF hospitalization using routinely reported CMR variables, patient-reported health status, and electronic health information.MethodsStandardized data capture was performed for 1,775 consecutive patients with chronic systolic HF referred for CMR imaging. Patient demographics, symptoms, Health-related Quality of Life, pharmacy, and routinely reported CMR features were provided to both machine learning (ML) and competing risk Fine-Gray-based models (FGM) for the prediction of time to HF hospitalization.ResultsThe mean age was 59 years with a mean LVEF of 36 ± 11%. The population was evenly distributed between ischemic (52%) and idiopathic non-ischemic cardiomyopathy (48%). Over a median follow-up of 2.79 years (IQR: 1.59–4.04) 333 patients (19%) experienced HF related hospitalization. Both ML and competing risk FGM based models achieved robust performance for the prediction of time to HF hospitalization. Respective 90-day, 1 and 2-year AUC values were 0.87, 0.83, and 0.80 for the ML model, and 0.89, 0.84, and 0.80 for the competing risk FGM-based model in a holdout validation cohort. Patients classified as high-risk by the ML model experienced a 34-fold higher occurrence of HF hospitalization at 90 days vs. the low-risk group.ConclusionIn this study we demonstrated capacity for routinely reported CMR phenotypic markers and patient health information to be combined for the delivery of patient-specific predictions of time to HF hospitalization. This work supports an evolving migration toward multi-domain data collection for the delivery of personalized risk prediction at time of diagnostic imaging.

Keywords